For the Inventor, By the Inventor

Enter assignee name

Waltham, MA, United States of America

Forum Pharmaceuticals, Inc.

USPTO Granted Patents = 9

CIPO Patents = 3

EPO Patents = 9

Forward Citations = 9

Loading Chart...

Loading Chart...

20 inventors (with patents filed for the assignee):

Richard Chesworth (8 out of 107 patents)

Gideon Shapiro (8 out of 74 patents)

Amy Ripka (3 out of 28 patents)

4. Patricia Oliver-Shaffer (3 out of 9 patents)

5. Muneki Kishida (3 out of 10 patents)

6. Takayuki Ishige (3 out of 5 patents)

7. Gerhard Koenig (2 out of 6 patents)

8. Yves Andre Chantigny (1 out of 7 patents)

9. Robert Deziel (1 out of 6 patents)

10. Dana C Hilt (1 out of 1 patent)

11. Patrick Beaulieu (1 out of 4 patents)

12. Silvana Leit (1 out of 11 patents)

13. John Mancuso (1 out of 3 patents)

14. Pierre Tessier (1 out of 6 patents)

15. David Smil (1 out of 5 patents)

9 patents: Sort by Forward Citations

1. 9585877 - Methods of maintaining, treating or improving cognitive function (2017-03-07),

2. 9550767 - Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate (2017-01-24),

3. 9273044 - Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate (2016-03-01),

4. 9265767 - 1,2-disubstituted heterocyclic compounds (2016-02-23),

5. 9193749 - Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors (2015-11-24),

6. 9108961 - Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride (2015-08-18),

7. 8946222 - Phenoxymethyl heterocyclic compounds (2015-02-03),

8. 8933074 - 1,2-disubstituted heterocyclic compounds (2015-01-13),

9. 8815933 - Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof (2014-08-26),

Forum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for central nervous system disorders. With a focus on rare genetic and neurodegenerative diseases, Forum Pharmaceuticals is committed to improving the lives of patients through cutting-edge research and development efforts.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

9 Patents

#121 in Waltham, MA

#1,866 in Massachusetts

#31,603 in US

Waltham, MA, United States of America

Forum Pharmaceuticals, Inc.

Forward Citations = 9

20 inventors:

Richard Chesworth (8 out of 107 patents)

Gideon Shapiro (8 out of 74 patents)

Amy Ripka (3 out of 28 patents)

4. Patricia Oliver-Shaffer (3 out of 9 patents)

5. Muneki Kishida (3 out of 10 patents)

Please report any incorrect information to support@idiyas.com

Loading…